Meta-analysis of liver venous deprivation vs portal vein embolization in treating liver cancer with an insufficient liver remnant
LVD demonstrates a superior performance over PVE in several key clinical outcomes and holds promise as a potential alternative for patients requiring preoperative FLR augmentation. However, further high-quality randomized controlled trials are warranted to validate its long-term efficacy and safety.
Authors
- Hong-Bo Mo (ORCID: https://orcid.org/0009-0005-6998-9069)
- Xinhua Cui
- Jiafei Che
- Ying Xie (ORCID: https://orcid.org/0000-0002-9535-8958)
- C. Xu (ORCID: https://orcid.org/0000-0002-9021-6731)
Institutions
- Zhejiang Hospital (CN)
- First Hospital of Jiaxing (CN)
Publication Details
- Journal
- Journal of the Chinese Medical Association
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1097/jcma.0000000000001313
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00